Cargando…
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
Autores principales: | Rizzo, M, Colomer-Asenjo, I, Sutil-Vega, M, Cabello-Molina, G, Marín-López, S, Taibi-Hajjami, F, Roca-Guerrero, C, García-Vega, D, Panelo-Rubio, M, Bonastre-Thio, M, Martínez-Rubio, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312472/ https://www.ncbi.nlm.nih.gov/pubmed/32612691 http://dx.doi.org/10.15420/ecr.2020.15.1.PO8 |
Ejemplares similares
-
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
por: Rizzo, M, et al.
Publicado: (2020) -
Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
por: Dewan, Pooja, et al.
Publicado: (2019) -
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
por: McMurray, John J V, et al.
Publicado: (2018) -
Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
por: Liu, Rex C.
Publicado: (2018) -
ECG Monitoring of Reactions to Sacubitril-valsartan in Heart Failure with Reduced Ejection Fraction
por: Kang, Min-Kyung
Publicado: (2020)